Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
Total Liabilities
Fuji Pharma Co Ltd
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
Total Liabilities
¥42.6B
|
CAGR 3-Years
24%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Total Liabilities
¥7.8T
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
14%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Total Liabilities
¥1.8T
|
CAGR 3-Years
30%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Total Liabilities
¥938.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Total Liabilities
¥255.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Astellas Pharma Inc
TSE:4503
|
Total Liabilities
¥2T
|
CAGR 3-Years
31%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
See Also
What is Fuji Pharma Co Ltd's Total Liabilities?
Total Liabilities
42.6B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Total Liabilities amounts to 42.6B JPY.
What is Fuji Pharma Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
10%
Over the last year, the Total Liabilities growth was 1%. The average annual Total Liabilities growth rates for Fuji Pharma Co Ltd have been 24% over the past three years , 21% over the past five years , and 10% over the past ten years .